CALGARY, ALBERTA--(Marketwire - July 28, 2008) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE: SSS) announced today that Dr. Allen Davidoff, VP Product Development, will be presenting data from the Phase I open labeled, uncontrolled pharmacokinetic study of a single intra-muscular (IM) hCG dose in healthy male volunteers at the IXth World Conference on Clinical Pharmacology and Therapeutics being held in Quebec City, Quebec, July 27th - August 1st, 2008.
